NFKB1 and lung cancer: CIGB-552 is a synthetic anti-tumor peptide that stimulates the ubiquitination of RelA, a subunit of NF-κB, in lung cancer cells, therefore decreasing the anti-apoptotic action of NF-κB and promoting the death of tumor cells.